Guillain-Barré syndrome reported in few Johnson & Johnson vaccine recipients: What is the rare nerve disorder?
July 13 2021, 08:00
A new warning from the Food and Drug Administration (FDA) over an elevated risk of a rare autoimmune nerve disorder among a small fraction of Johnson & Johnson COVID-19 vaccine recipients has sparked concern: What is Guillain-Barré syndrome?
A new warning from the Food and Drug Administration (FDA) over an elevated risk of a rare autoimmune nerve disorder among a small fraction of Johnson & Johnson COVID-19 vaccine recipients has sparked concern: What is Guillain-Barré syndrome?
Source:
FOX News
